ArticleCancer biology & therapy2015

Downregulation of hPMC2 imparts chemotherapeutic sensitivity to alkylating agents in breast cancer cells.

Nirmala Krishnamurthy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.